Browse studies

Find your next paid study

3,843 recruiting studies matching your filters

ROSETTA Lung-202: A Randomized, Double-Blind, Phase 3 Study of Pumitamig Monotherapy Compared to Pembrolizumab as First-line Treatment in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥ 50%.

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung …

Non-Small Cell Lung Cancer (NSCLC)

Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT07361510

EXERT-BCHC: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

This study investigates the impact of four standard of care, monitored group exercise regimens (resistance training) on conditioning and hypertrophy in women p…

CancerBreast Cancer

Estimated

~$10 – $1,125

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07023887

Phase 1

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Advanced Solid Tumors

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects…

NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more

Estimated

~$10 – $8,750

TwoStep Therapeutics, Inc.NCT07814248

Observational

Implementing Stepped Financial and Legal Navigation to Mitigate Financial Toxicity in Adolescent and Young Adult Cancer Patients Oncology Financial and Legal Navigation (OFLN)

The overall objective of this study is to test the effectiveness and implementability of stepped OFLN in a noninferiority randomized controlled trial (RCT) usi…

Adolescent and Young Adult CancerFinancial Toxicity

Estimated

~$10 – $6,250

University of LouisvilleNCT07849699

Phase 4

Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy

This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prosta…

Androgen Deprivation TherapyProstate CancerHypertension+2 more

Estimated

~$10 – $6,250

Virginia Commonwealth UniversityNCT07848828

Observational

Piloting Single Session Consultation for Cancer (SSC-C) to Alleviate Distress Among Cancer Patients

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with …

Breast Cancer

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07218250

Phase 3

A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE ENFORTUMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN ADULT PARTICIPANTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ARE INELIGIBLE FOR OR HAVE ELECTED NOT TO UNDERGO CYSTECTOMY

This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together as a bladder preservation approach to treat patients wi…

Urothelial CancerUrinary Bladder Neoplasms

Estimated

~$10 – $8,750

Astellas Pharma Global Development, Inc.NCT07566156

Phase 1

A Phase 1 First-in-Human, Open-Label Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-901 as a Monotherapy and in Combination in Adult Subjects With Ovarian Cancer

Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV901, alone or in combination w…

Addressing Health Literacy With a Tailored Survivorship Care Plan to Improve Access in Underserved African American Prostate Cancer Patients

This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in…

Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

Estimated

~$10 – $6,250

Emory UniversityNCT06674863

Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository

This study collects health and genetic information to implement cancer prevention and treatment strategies.

CancerGeneticsDisease+2 more

Estimated

~$10 – $750

Texas A&M UniversityNCT06826014

Phase 1

A Phase Ib/II, Open-label, Safety and Tolerability Trial of Intravenous Obrixtamig in Combination With Pumitamig and Standard of Care (Carboplatin, Etoposide) in Patients With Extensive-stage Small Cell Lung Carcinoma

This study is open to adults with extensive-stage small cell lung cancer. The purpose of this study is to find out how well people with this type of cancer tol…

Extensive-stage Small Cell Lung CarcinomaAdvanced Small Cell Lung Cancer

Estimated

~$10 – $7,500

Boehringer IngelheimNCT07843940

Phase 2

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

This is a phase II study aiming at evaluating capecitabine prospectively at a dose of 1000 mg once daily in patients with advanced breast cancer who are ≥60 ye…

Metastatic Breast Cancer

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT06105684